Rentokil Initial plc
NYSE:RTOSpecialty Business Services
-$1.31 today
- Market cap
- $11.86B
- Beta
- 0.42
- P/E (TTM)
- 35.4
- EPS (TTM)
- $0.12
- Dividend yield
- 2.15%
Volume 1.08M
Average 0.99M
RTO Income Before Tax
Profit after all operating and non-operating items but before income tax.
Rentokil Initial plcNYSE: RTO
Income Before Tax · Q4 FY2025 · quarter ended Dec 2025
Income before tax grows 13.9% year over year
Q4 FY2025 income before tax of $173.11M rose 13.9% year over year. Over 3 fiscal years it compounded at +9.7% a year.
Context
- Income before tax amounted to 5.6% of revenue in FY2025, down 1.8 pp from a year earlier.
- Income before tax increased in 1 of the last 3 fiscal years.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Before Tax history
Mixed currencies · from the income statement
- Latest · FY2025
- 390.37M USD
- Year-over-year change
- —
| Period | Period end | Income Before Tax | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 390.37M | — |
| FY2024 | 2024-12-31 | 405M | -17.8% |
| FY2023 | 2023-12-31 | 493M | +66.6% |
| FY2022 | 2022-12-31 | 296M | -8.9% |
| FY2021 | 2021-12-31 | 325M | — |
Income Before Tax vs competitors
How RTO compares with its peers on the latest reported figures
- RTO's FY2025 income before tax of $390.37M is the 5th highest of the 6 companies compared; the peer median is $694.15M.
- Its year-over-year change of -3.6% is the 5th highest of 6, against a peer median of +0.4%.
- Income before tax amounts to 5.6% of revenue for RTO, versus a peer median of 15.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.63B | -2.3% | +23.8% | 15.6% | |
| LTM Aug 2026 | $2.6B | +11.9% | +14.0% | 22.5% | |
| LTM Sep 2026 | $694.15M | +0.4% | +12.0% | 17.4% | |
| LTM Oct 2026 | $595.88M | +38.4% | +1.9% | 3.0% | |
| FY2025 | $390.37M | -3.6% | +9.7% | 5.6% | |
| LTM Aug 2026 | $142.07M | -27.3% | +0.8% | 5.6% | |
| Peer median (excluding RTO) | $694.15M | +0.4% | +12.0% | 15.6% | |
Competitors are the stored peer set for RTO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 · GBP | FY2022 Dec 2022 · GBP | FY2023 Dec 2023 · GBP | FY2024 Dec 2024 · GBP | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Revenue | 2.95B | 3.71B | 5.38B | 5.44B | 6.91B |
| Cost of Revenue | 596M | 704M | 927M | 4.71B | 4.66B |
| Gross Profit | 728.72M | 3.01B | 4.45B | 726M | 2.27B |
| Gross Margin | 24.7% | 81.0% | 82.8% | 13.4% | 32.8% |
| Research & Development | 5M | 5M | 0 | 7M | 0 |
| Selling, General & Admin | 348.6M | 479M | 2.87B | 0 | 0 |
| Operating Expenses | 2.01B | 2.69B | 3.82B | 177M | 1.32B |
| Depreciation & Amortization | 202M | 258M | 475M | 320M | 563.53M |
| EBITDA | 580M | 748M | 1.16B | 990M | 1.51B |
| EBITDA Margin | 19.6% | 20.1% | 21.5% | 18.2% | 21.8% |
| Operating Income | 347M | 317M | 625M | 549M | 945.89M |
| Operating Margin | 11.7% | 8.5% | 11.6% | 10.1% | 13.7% |
| Interest Income | 1M | 5M | 25M | 36M | 31.03M |
| Interest Expense | 34M | 77M | 189M | 192M | 60.06M |
| Other Income / Expenses | (22M) | (21M) | (132M) | (144M) | (555.52M) |
| Income Before Tax | 325M | 296M | 493M | 405M | 390.37M |
| Pre-Tax Margin | 11.0% | 8.0% | 9.2% | 7.5% | 5.6% |
| Income Tax Expense | 61.9M | 64M | 112M | 98M | 100.09M |
| Net Income | 263M | 232M | 381M | 307M | 470.44M |
| Net Margin | 8.9% | 6.2% | 7.1% | 5.6% | 6.8% |
| EPS (Basic) | 0.70 | 0.60 | 0.75 | 0.60 | 0.95 |
| EPS (Diluted) | 0.70 | 0.60 | 0.75 | 0.60 | 0.95 |
| Weighted Avg Shares | 371.62M | 400.4M | 503.2M | 505.77M | 504.8M |
| Weighted Avg Shares (Diluted) | 373.26M | 402.8M | 505.4M | 505.6M | 507M |
Rentokil Initial plc
NYSE:RTO
Intrinsic Alpha fair value
Locked
Current Price
$23.58
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.